This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Sanofi Shortens Shelf Life of Some H1N1 Vaccine Doses
Expiration Dates Moved Up for Prefilled Syringes
By News Staff
According to CDC officials, 50 vaccine lots were subject to the change in expiration date. The lots, which represent about 12 million doses, originally had expiration dates ranging from March 4, 2011, to June 11, 2011.
"The actual number of unused doses is likely much, much lower because most of those doses were shipped early in the season when things were being used immediately," said Anne Schuchat, M.D., director of the CDC's National Center for Immunization and Respiratory Diseases, during a Feb. 5 media briefing.
Prefilled syringes not used by Feb. 15 should be discarded in an appropriate manner or returned to Sanofi Pasteur Inc., the CDC said.
According to Schuchat, the FDA and vaccine manufacturers are looking into why some H1N1 vaccine lots have had potency issues.
In December, AstraZeneca's MedImmune biologics unit recalled 4.7 million doses of its live, attenuated intranasal H1N1 vaccine after nine lots failed stability testing.
Sanofi Pasteur's recalls covered nine lots of pediatric vaccine (0.25 mL) and one lot of vaccine for older children and adults (0.5 mL). More than 2 million doses were affected.
The CDC said there are no safety concerns with the vaccine, and people who received vaccine from the recalled lots or the lots with a shortened shelf life do not need to take any action. The agency also noted that the recalls and shortened expiration dates do not affect Sanofi Pasteur's H1N1 vaccine in multidose vials.
Schuchat said during the Feb. 5 media briefing that 124 million doses of H1N1 vaccine have been shipped, and about 70 million Americans have been immunized using 76 million doses (children under 10 are recommended to receive two doses). That works out to about 23 percent of Americans who have been vaccinated, she said, including 37 percent of children.
Sanofi Pasteur Recalls Pediatric H1N1 Vaccine
Potency at Issue in Four Lots of Prefilled Syringes
MedImmune Recalls 13 Lots of Intranasal H1N1 Vaccine
Potency Again at Issue in Second Vaccine Recall
More From AAFP
CDC: "Shortened Expiration Period for Sanofi Pasteur 2009 H1N1 Vaccine in Prefilled Syringes Q&A"
(Feb. 4, 2010)
CDC: 2009 H1N1 Flu: Situation Update